POTELIGEO (mogamulizumab-kpkc)

**Product type:** Human Prescription Drug

**Active ingredient:** MOGAMULIZUMAB

**Strength:** 4 mg/mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** Kyowa Kirin, Inc.

**Marketing category:** BLA (BLA761051)

**Pharmacologic class:** Antibodies, Monoclonal [CS], Chemokine Receptor Type 4 Interaction [EPC], Chemokine Receptor Type 4 Interactions [MoA], Monoclonal Antibody [EPC]